Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(38:3e)/PE(38:2p) | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 225 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 318 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 293 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 203 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 193 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 195 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 105 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 162 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | C | 0.0 | BCD100427B001 | 248 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | C | 0.5 | BCD100427B003 | 230 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | C | 1.0 | BCD100427B007 | 380 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | C | 2.0 | BCD100427B011 | 189 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | C | 4.0 | BCD100427B015 | 212 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | C | 8.0 | BCD100427B019 | 178 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | C | 12.0 | BCD100427B023 | 158 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | C | 24.0 | BCD100427B027 | 118 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 224 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 211 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 198 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 196 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 213 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 93.6 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 154 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol | 0.5 | BCD100427B004 | 370 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol | 1.0 | BCD100427B008 | 190 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol | 2.0 | BCD100427B012 | 401 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol | 4.0 | BCD100427B016 | 307 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol | 8.0 | BCD100427B020 | 136 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol | 12.0 | BCD100427B024 | 201 | pmol/sample |
| - | PE(38:3e)/PE(38:2p) | 25OH-Chol | 24.0 | BCD100427B028 | 59.3 | pmol/sample |